Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
New treatment for narrowed urethra under scrutiny for sperm effects
Disease control Recruiting nowThis study looks at how a treatment called Optilume affects sperm quality in men with a narrowed urethra. About 34 men aged 22 to 65 will be treated and followed for 6 months. The main goal is to see if sperm concentration changes after treatment.
Phase: PHASE4 • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated May 26, 2026 06:36 UTC
-
New balloon treatment could open blocked ureters without surgery
Disease control Recruiting nowThis study tests a special balloon coated with medicine (Optilume DCB) to open narrowed ureters, the tubes that carry urine from the kidneys to the bladder. About 60 adults with a single stricture up to 4 cm long will be treated. The goal is to see if the balloon is safe and work…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated May 26, 2026 06:33 UTC
-
New catheter device aims to ease prostate troubles in men
Symptom relief Recruiting nowThis study is tracking 500 men who receive the Optilume BPH Catheter System to treat symptoms of an enlarged prostate, like frequent or difficult urination. The goal is to see how well the device improves symptom scores and how safe it is in everyday use. Participants are treated…
Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated May 26, 2026 06:33 UTC
-
New catheter aims to relieve prostate trouble without surgery
Symptom relief Recruiting nowThis study tests a device called Optilume that is placed through the penis to open up the prostate and improve urine flow. It is for men aged 50 and older with moderate to severe symptoms from an enlarged prostate. The goal is to see if the device safely reduces symptoms like fre…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC